These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15665380)

  • 1. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATPase mechanism of Eg5 in the absence of microtubules: insight into microtubule activation and allosteric inhibition by monastrol.
    Cochran JC; Gilbert SP
    Biochemistry; 2005 Dec; 44(50):16633-48. PubMed ID: 16342954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
    Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
    Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.
    Wojcik EJ; Dalrymple NA; Alford SR; Walker RA; Kim S
    Biochemistry; 2004 Aug; 43(31):9939-49. PubMed ID: 15287721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic analysis of the mitotic kinesin Eg5.
    Cochran JC; Sontag CA; Maliga Z; Kapoor TM; Correia JJ; Gilbert SP
    J Biol Chem; 2004 Sep; 279(37):38861-70. PubMed ID: 15247293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural model for monastrol inhibition of dimeric kinesin Eg5.
    Krzysiak TC; Wendt T; Sproul LR; Tittmann P; Gross H; Gilbert SP; Hoenger A
    EMBO J; 2006 May; 25(10):2263-73. PubMed ID: 16642039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
    Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
    J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.
    Krzysiak TC; Gilbert SP
    J Biol Chem; 2006 Dec; 281(51):39444-54. PubMed ID: 17062577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway of ATP hydrolysis by monomeric kinesin Eg5.
    Cochran JC; Krzysiak TC; Gilbert SP
    Biochemistry; 2006 Oct; 45(40):12334-44. PubMed ID: 17014086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eg5 is static in bipolar spindles relative to tubulin: evidence for a static spindle matrix.
    Kapoor TM; Mitchison TJ
    J Cell Biol; 2001 Sep; 154(6):1125-33. PubMed ID: 11564753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
    Chin GM; Herbst R
    Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.
    Learman SS; Kim CD; Stevens NS; Kim S; Wojcik EJ; Walker RA
    Biochemistry; 2009 Mar; 48(8):1754-62. PubMed ID: 19236100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration.
    Garcia-Saez I; DeBonis S; Lopez R; Trucco F; Rousseau B; Thuéry P; Kozielski F
    J Biol Chem; 2007 Mar; 282(13):9740-9747. PubMed ID: 17251189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-steady-state kinetics of the microtubule-kinesin ATPase.
    Gilbert SP; Johnson KA
    Biochemistry; 1994 Feb; 33(7):1951-60. PubMed ID: 8110800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
    Peters T; Lindenmaier H; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamics of nucleotide and inhibitor binding to wild-type and ispinesib-resistant forms of human kinesin spindle protein.
    Sheth PR; Basso A; Duca JS; Lesburg CA; Ogas P; Gray K; Nale L; Mannarino AF; Prongay AJ; Le HV
    Biochemistry; 2009 Nov; 48(46):11045-55. PubMed ID: 19824700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
    Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
    Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.